CancerWorld/X
Aug 1, 2025, 11:27
Africa Builds Its Own Cancer Atlas – CancerWorld
CancerWorld shared a post on X:
“Africa Builds Its Own Cancer Atlas.
In oncology today, precision medicine is only as precise as the DATA behind it. Yet, LESS THAN 2% of genomic data used in cancer research comes from African populations. That gap is a global blind spot.
Now, a bold initiative is changing the narrative.
Yemaachi Biotech, a Ghana-based company, is leading The African Cancer Atlas (TACA), a landmark effort to sequence 15,000 cancer genomes across the continent.
With support from over 25 hospitals across 9 African countries and early backing from Roche, TACA aims to:
- Improve treatment outcomes for African patients
- Empower local researchers with cutting-edge genomic tools
- Uncover new insights that benefit all cancer patients worldwide
Read the full CancerWorld article.”
More posts featuring CancerWorld.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32